Bio Green Med Solution, Inc. — Director's Dealing 2010

Jun 11, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2010-06-09

Reporting Person: Rombotis Spiro George (Director, President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-06-09	Common Stock, $0.001 par value per share	M	75000	$0.44	Acquired	558198	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-09	Option	$0.44	M	75000	Disposed	2018-11-18	Common Stock (75000)	Direct

Footnotes

F1: Of the shares of common stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account and 30,206 shares are represented by unvested restricted stock units.

F2: These securities were granted to Mr. Rombotis under the Issuer's Amended and Restated 2006 Equity Incentive Plan.